These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back. Chau NG; Lorch JH Oncologist; 2015 Jul; 20(7):699-701. PubMed ID: 26040619 [TBL] [Abstract][Full Text] [Related]
5. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. Farwell MD; Clark AS; Mankoff DA JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243 [No Abstract] [Full Text] [Related]
6. Understanding the Precision in "Precision Medicine". Chabner BA Oncologist; 2016 Sep; 21(9):1029-30. PubMed ID: 27566249 [TBL] [Abstract][Full Text] [Related]
7. [Clinical studies in oncology--a challenge for clinical and academic pathology]. Röcken C Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265 [No Abstract] [Full Text] [Related]
8. Health: Make precision medicine work for cancer care. Rubin MA Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189 [No Abstract] [Full Text] [Related]
9. Is genome-guided cancer treatment hyped? Kaiser J Science; 2018 Apr; 360(6387):365. PubMed ID: 29700244 [No Abstract] [Full Text] [Related]
10. American Society of Clinical Oncology Developing First Clinical Trial. Brower V J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625 [No Abstract] [Full Text] [Related]
12. NCI-MATCH launch highlights new trial design in precision-medicine era. McNeil C J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446 [No Abstract] [Full Text] [Related]
13. The landscape of precision cancer medicine clinical trials in the United States. Roper N; Stensland KD; Hendricks R; Galsky MD Cancer Treat Rev; 2015 May; 41(5):385-90. PubMed ID: 25864024 [TBL] [Abstract][Full Text] [Related]
14. The SHIVA01 trial: what have we learned? Le Tourneau C; Kamal M; Bièche I Pharmacogenomics; 2017 Jun; 18(9):831-834. PubMed ID: 28594293 [No Abstract] [Full Text] [Related]
15. [Pharmaceutical Sciences Advancing Molecular Cancer Therapeutics~To Improve Rationale and Effectiveness of Molecularly Targeted Drugs~]. Noguchi K; Mashima T Yakugaku Zasshi; 2017; 137(2):127-128. PubMed ID: 28154318 [No Abstract] [Full Text] [Related]
16. Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing. Hafez N; Walther Z; Eder JP; Sklar JL; Gettinger SN; Finberg KE; Goldberg SB Lancet Oncol; 2020 Mar; 21(3):343-344. PubMed ID: 32950226 [No Abstract] [Full Text] [Related]
17. Better Outcomes with Precision Medicine. Cancer Discov; 2016 Dec; 6(12):1296-1297. PubMed ID: 27784709 [TBL] [Abstract][Full Text] [Related]
18. Perspective: The precision-oncology illusion. Prasad V Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743 [No Abstract] [Full Text] [Related]
19. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. Do K; O'Sullivan Coyne G; Chen AP Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298 [TBL] [Abstract][Full Text] [Related]
20. The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big Data. Kim ES Am Soc Clin Oncol Educ Book; 2015; ():22-7. PubMed ID: 25993137 [No Abstract] [Full Text] [Related] [Next] [New Search]